First Time Loading...

XBiotech Inc
NASDAQ:XBIT

Watchlist Manager
XBiotech Inc Logo
XBiotech Inc
NASDAQ:XBIT
Watchlist
Price: 8.74 USD 2.34% Market Closed
Updated: May 22, 2024

Intrinsic Value

XBIT's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. [ Read More ]

The intrinsic value of one XBIT stock under the Base Case scenario is 3.56 USD. Compared to the current market price of 8.74 USD, XBiotech Inc is Overvalued by 59%.

Key Points:
XBIT Intrinsic Value
Base Case
3.56 USD
Overvaluation 59%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
XBiotech Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling XBIT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
XBiotech Inc

Provide an overview of the primary business activities
of XBiotech Inc.

What unique competitive advantages
does XBiotech Inc hold over its rivals?

What risks and challenges
does XBiotech Inc face in the near future?

Has there been any significant insider trading activity
in XBiotech Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for XBiotech Inc.

Provide P/S
for XBiotech Inc.

Provide P/E
for XBiotech Inc.

Provide P/OCF
for XBiotech Inc.

Provide P/FCFE
for XBiotech Inc.

Provide P/B
for XBiotech Inc.

Provide EV/S
for XBiotech Inc.

Provide EV/GP
for XBiotech Inc.

Provide EV/EBITDA
for XBiotech Inc.

Provide EV/EBIT
for XBiotech Inc.

Provide EV/OCF
for XBiotech Inc.

Provide EV/FCFF
for XBiotech Inc.

Provide EV/IC
for XBiotech Inc.

Show me price targets
for XBiotech Inc made by professional analysts.

What are the Revenue projections
for XBiotech Inc?

How accurate were the past Revenue estimates
for XBiotech Inc?

What are the Net Income projections
for XBiotech Inc?

How accurate were the past Net Income estimates
for XBiotech Inc?

What are the EPS projections
for XBiotech Inc?

How accurate were the past EPS estimates
for XBiotech Inc?

What are the EBIT projections
for XBiotech Inc?

How accurate were the past EBIT estimates
for XBiotech Inc?

Compare the revenue forecasts
for XBiotech Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of XBiotech Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of XBiotech Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of XBiotech Inc compared to its peers.

Compare the P/E ratios
of XBiotech Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing XBiotech Inc with its peers.

Analyze the financial leverage
of XBiotech Inc compared to its main competitors.

Show all profitability ratios
for XBiotech Inc.

Provide ROE
for XBiotech Inc.

Provide ROA
for XBiotech Inc.

Provide ROIC
for XBiotech Inc.

Provide ROCE
for XBiotech Inc.

Provide Gross Margin
for XBiotech Inc.

Provide Operating Margin
for XBiotech Inc.

Provide Net Margin
for XBiotech Inc.

Provide FCF Margin
for XBiotech Inc.

Show all solvency ratios
for XBiotech Inc.

Provide D/E Ratio
for XBiotech Inc.

Provide D/A Ratio
for XBiotech Inc.

Provide Interest Coverage Ratio
for XBiotech Inc.

Provide Altman Z-Score Ratio
for XBiotech Inc.

Provide Quick Ratio
for XBiotech Inc.

Provide Current Ratio
for XBiotech Inc.

Provide Cash Ratio
for XBiotech Inc.

What is the historical Revenue growth
over the last 5 years for XBiotech Inc?

What is the historical Net Income growth
over the last 5 years for XBiotech Inc?

What is the current Free Cash Flow
of XBiotech Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for XBiotech Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
XBiotech Inc

Current Assets 201.7m
Cash & Short-Term Investments 200m
Receivables 935k
Other Current Assets 760k
Non-Current Assets 24.9m
PP&E 24.9m
Current Liabilities 6.1m
Accounts Payable 2.5m
Accrued Liabilities 3.5m
Other Current Liabilities 83k
Non-Current Liabilities 1.7m
Other Non-Current Liabilities 1.7m
Efficiency

Earnings Waterfall
XBiotech Inc

Revenue
0 USD
Operating Expenses
-37.5m USD
Operating Income
-37.5m USD
Other Expenses
13m USD
Net Income
-24.6m USD

Free Cash Flow Analysis
XBiotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

XBIT Profitability Score
Profitability Due Diligence

XBiotech Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

21/100
Profitability
Score

XBiotech Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

XBIT Solvency Score
Solvency Due Diligence

XBiotech Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

XBiotech Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

XBIT Price Targets Summary
XBiotech Inc

Wall Street analysts forecast XBIT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XBIT is 18 USD .

Lowest
Price Target
Not Available
Average
Price Target
18 USD
106% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Competitors Analysis
XBiotech Inc

Ownership

XBIT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

XBIT Price
XBiotech Inc

1M 1M
+10%
6M 6M
+144%
1Y 1Y
+73%
3Y 3Y
-49%
5Y 5Y
-4%
10Y 10Y
-54%
Annual Price Range
8.74
52w Low
3.56
52w High
9.89
Price Metrics
Average Annual Return -0.79%
Standard Deviation of Annual Returns 78.83%
Max Drawdown -88%
Shares Statistics
Market Capitalization 266m USD
Shares Outstanding 30 457 500
Percentage of Shares Shorted 3.98%

XBIT Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

XBiotech Inc Logo
XBiotech Inc

Country

United States of America

Industry

Biotechnology

Market Cap

266m USD

Dividend Yield

0%

Description

XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. The company is headquartered in Austin, Texas and currently employs 97 full-time employees. The company went IPO on 2015-04-15. The firm is focused on the therapies that block a potent substance naturally produced by body, known as interleukin-1 alpha (IL-1a), that mediates tissue breakdown, angiogenesis, the formation of blood clots and inflammation. IL-1a is a protein that is on or in cells of the body and is involved in the body’s response to injury or trauma. Its True Human antibodies have the potential to harness the body's natural immunity to fight disease with increased safety, efficacy and tolerability. The firm has developed a pipeline of product candidates targeting both inflammatory and infectious diseases. The firm is developing a pipeline of product candidates targeting both inflammatory and infectious diseases and has developed commercial scale manufacturing technology and infrastructure.

Contact

TEXAS
Austin
5217 WINNEBAGO LANE, BUILDING 4, SUITE 100
+15123862900.0
http://www.xbiotech.com/

IPO

2015-04-15

Employees

97

Officers

Founder, President, CEO & Chairman
Mr. John Simard
Chief Scientific Officer
Dr. Sushma Shivaswamy Ph.D.
Director of Finance, Principal Financial & Accounting Officer and Financial Controller
Ms. Angela Hu

See Also

Discover More
What is the Intrinsic Value of one XBIT stock?

The intrinsic value of one XBIT stock under the Base Case scenario is 3.56 USD.

Is XBIT stock undervalued or overvalued?

Compared to the current market price of 8.74 USD, XBiotech Inc is Overvalued by 59%.